
Naamit Kurshan Gerber MD
Breast Cancer
Faculty, NYU Langone Medical Center
Join to view full profile
160 E 34th StreetDepartment of Radiation OncologyNew York, NY 10016
Phone+1 212-731-6033
Dr. Gerber is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Naamit Gerber is a radiation oncology specialist based in New York, NY. She completed her residency and internship at the Memorial Sloan Kettering Cancer Center and is a graduate of the Icahn School of Medicine at Mount Sinai. Dr. Gerber has contributed to the knowledge pool within her field through various publications, with notable focus on the subjects of partial breast irradiation and the impact of radiation dermatitis in patients with skin of color. Dr. Gerber is also involved in conducting clinical trials, including research into total body irradiation, efficacy of a caffeine-based antifibrosis cream, and a study comparing Deep Inspiratory Breath Hold with Prone Breast Irradiation.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2011 - 2015
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2010 - 2011
Icahn School of Medicine at Mount SinaiClass of 2010
Harvard UniversityAB, History of Science, Summa cum laude, 1998 - 2002
Certifications & Licensure
NY State Medical License 2011 - 2026
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Clinical Trials
- A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation Start of enrollment: 2017 Jan 17
- Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy Start of enrollment: 2020 Jun 29
- A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT Start of enrollment: 2020 Sep 22
Publications & Presentations
PubMed
- Initiation and Completion of Hormone Therapy in Older Women With Early-Stage Breast Cancer.Jerome M Karp, Freya Schnabel, Julie Xiao, Cheongeun Oh, Sylvia Adams
International Journal of Radiation Oncology, Biology, Physics. 2026-07-15 - Curietherapy User eXperience Pilot Study (CurieUx): A Feasibility Study of a Novel Augmented Reality Educational Tool During Radiation Oncology Consultation for Patien...David J Byun, Elisa K Liu, Olivier Maisonet, Julie Xiao, Kevin L Du
International Journal of Radiation Oncology, Biology, Physics. 2026-07-15 - In Reply to Altundag and Altundag.Jerome M Karp, Naamit Kurshan Gerber
International Journal of Radiation Oncology, Biology, Physics. 2026-07-15
Journal Articles
- ASO Author Reflections: The Role of Post-Mastectomy Radiation Therapy in the Setting of Nodal MicrometastasesNaamit Gerber, MD, Annals of Surgical Oncology
- Neoadjuvant Chemotherapy in Local‐Regionally Advanced Nasopharyngeal Carcinoma: A National Cancer Database AnalysisBabak Givi, Kenneth Hu, Moses Tam, Naamit K Gerber, S Peter Wu, Anna Lee, Zujun Li, The Laryngoscope
Press Mentions
Breast Cancer: Radiation May Not Affect Survival in Some Patients 65 and Older, New Study SuggestsFebruary 17th, 2023
Breast Cancer: Radiation for Certain Patients 65 and Older May Not Affect Their Survival, New Study SuggestsFebruary 17th, 2023
More Women with Breast Cancer Could Skip Harsh Radiation, Study SaysFebruary 16th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









